catalyst

Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia — primary completion

as of 2026-07-01
Monitor thisAsk about this
at a glance
2024-04-30 · Actual — This event happened.
Synthesized from structured facts only — each point cited above.

Event

What
Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia — primary completion
Type
Trial Readout
Date
2024-04-30
Date type
ACTUAL
Phase
Phase 3
This event happened.
relationships
The graph out of here
trial
Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia
trial